DCPLA-ME

• Description :

  DCPLA-ME, the methyl ester form of DCPLA, is a potent PKCε activator for use in the treatment of neurodegenerative diseases[1].

• Product Name Alternative :

  DCPLA methyl ester

• UNSPSC :

  12352211

• Target :

  PKC

• Type :

  Reference compound

• Related Pathways :

  Epigenetics; TGF-beta/Smad

• Applications :

  Neuroscience-Neurodegeneration

• Field of Research :

  Neurological Disease

• Assay Protocol :

  https://www.medchemexpress.com/dcpla-me.html

• Purity :

  98.0

• Solubility :

  DMSO : 15.62 mg/mL (ultrasonic)

• Smiles :

  O=C(OC)CCCCCCCC1C(CC2C(CCCCC)C2)C1

• Molecular Formula :

  C21H38O2

• Molecular Weight :

  322.53

• References & Citations :

  [1]Thomas J. Nelson, et al. Halogenated esters of cyclopropanated unsaturated fatty acids for use in the treatment of neurodegenerative diseases. WO2015058191A1.

• Shipping Conditions :

  Room Temperature

• Storage Conditions :

  -20°C, 3 years; 4°C, 2 years (Powder)

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• Isoform :

  PKCε

• CAS Number :

  [56687-67-3]